Cargando…

Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial

BACKGROUND: Maintaining independence in older age is an important aspect of quality of life. We investigated depressive symptoms as an important modifiable risk factor that may mediate the effects of physical and cognitive decline on disability. METHODS: We prospectively analyzed data from 223 adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Buss, Stephanie S., Aponte Becerra, Laura, Trevino, Jorge, Fortier, Catherine B., Ngo, Long H., Novak, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707770/
https://www.ncbi.nlm.nih.gov/pubmed/36445876
http://dx.doi.org/10.1371/journal.pone.0278319
_version_ 1784840770138669056
author Buss, Stephanie S.
Aponte Becerra, Laura
Trevino, Jorge
Fortier, Catherine B.
Ngo, Long H.
Novak, Vera
author_facet Buss, Stephanie S.
Aponte Becerra, Laura
Trevino, Jorge
Fortier, Catherine B.
Ngo, Long H.
Novak, Vera
author_sort Buss, Stephanie S.
collection PubMed
description BACKGROUND: Maintaining independence in older age is an important aspect of quality of life. We investigated depressive symptoms as an important modifiable risk factor that may mediate the effects of physical and cognitive decline on disability. METHODS: We prospectively analyzed data from 223 adults (age 50–85; 117 controls and 106 with type-2 diabetes) over 48 weeks who were participating in a clinical trial “Memory Advancement by Intranasal Insulin in Type 2 Diabetes.” Data from self-reported disability (World Health Organization Disability Assessment Schedule) and depressive symptoms (Geriatric Depression Scale) were obtained from baseline, week 25, and week 48 visits. Cognition (Mini-mental status examination) and medical comorbidities (Charlson Comorbidity Index) were assessed at baseline. Longitudinal analysis assessed the extent to which change in depressive symptoms predicted worsening disability. Mediation analyses were performed to determine the extent to which depressive symptoms accounted for disability associated with worse cognition, walking speed, and comorbidities. RESULTS: At baseline, depressive symptoms, cognition, and walking speed were within normal limits, but participants had a high 10-year risk of cardiovascular mortality. Depressive symptoms were related to disability at baseline (p<0.001), and longitudinally (p<0.001). Cognition, walking speed, and comorbidities were associated with disability at baseline (p-values = 0.027–0.001). Depressive symptoms had a large mediating effect on disability longitudinally: the indirect effect on disability via depression accounts for 51% of the effect of cognition, 34% of the effect of mobility, and 24% of the effect of comorbidities. CONCLUSIONS: Depressive symptoms substantially exacerbated the effects of worsening cognition, gait speed, and comorbidities on disability. In our sample, most individuals scored within the “normal” range of the Geriatric Depression Scale, suggesting that even subclinical symptoms can lead to disability. Treating subclinical depression, which may be under-recognized in older adults, should be a public health priority to help preserve independence with aging.
format Online
Article
Text
id pubmed-9707770
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-97077702022-11-30 Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial Buss, Stephanie S. Aponte Becerra, Laura Trevino, Jorge Fortier, Catherine B. Ngo, Long H. Novak, Vera PLoS One Research Article BACKGROUND: Maintaining independence in older age is an important aspect of quality of life. We investigated depressive symptoms as an important modifiable risk factor that may mediate the effects of physical and cognitive decline on disability. METHODS: We prospectively analyzed data from 223 adults (age 50–85; 117 controls and 106 with type-2 diabetes) over 48 weeks who were participating in a clinical trial “Memory Advancement by Intranasal Insulin in Type 2 Diabetes.” Data from self-reported disability (World Health Organization Disability Assessment Schedule) and depressive symptoms (Geriatric Depression Scale) were obtained from baseline, week 25, and week 48 visits. Cognition (Mini-mental status examination) and medical comorbidities (Charlson Comorbidity Index) were assessed at baseline. Longitudinal analysis assessed the extent to which change in depressive symptoms predicted worsening disability. Mediation analyses were performed to determine the extent to which depressive symptoms accounted for disability associated with worse cognition, walking speed, and comorbidities. RESULTS: At baseline, depressive symptoms, cognition, and walking speed were within normal limits, but participants had a high 10-year risk of cardiovascular mortality. Depressive symptoms were related to disability at baseline (p<0.001), and longitudinally (p<0.001). Cognition, walking speed, and comorbidities were associated with disability at baseline (p-values = 0.027–0.001). Depressive symptoms had a large mediating effect on disability longitudinally: the indirect effect on disability via depression accounts for 51% of the effect of cognition, 34% of the effect of mobility, and 24% of the effect of comorbidities. CONCLUSIONS: Depressive symptoms substantially exacerbated the effects of worsening cognition, gait speed, and comorbidities on disability. In our sample, most individuals scored within the “normal” range of the Geriatric Depression Scale, suggesting that even subclinical symptoms can lead to disability. Treating subclinical depression, which may be under-recognized in older adults, should be a public health priority to help preserve independence with aging. Public Library of Science 2022-11-29 /pmc/articles/PMC9707770/ /pubmed/36445876 http://dx.doi.org/10.1371/journal.pone.0278319 Text en © 2022 Buss et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Buss, Stephanie S.
Aponte Becerra, Laura
Trevino, Jorge
Fortier, Catherine B.
Ngo, Long H.
Novak, Vera
Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial
title Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial
title_full Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial
title_fullStr Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial
title_full_unstemmed Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial
title_short Depressive symptoms exacerbate disability in older adults: A prospective cohort analysis of participants in the MemAID trial
title_sort depressive symptoms exacerbate disability in older adults: a prospective cohort analysis of participants in the memaid trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707770/
https://www.ncbi.nlm.nih.gov/pubmed/36445876
http://dx.doi.org/10.1371/journal.pone.0278319
work_keys_str_mv AT bussstephanies depressivesymptomsexacerbatedisabilityinolderadultsaprospectivecohortanalysisofparticipantsinthememaidtrial
AT apontebecerralaura depressivesymptomsexacerbatedisabilityinolderadultsaprospectivecohortanalysisofparticipantsinthememaidtrial
AT trevinojorge depressivesymptomsexacerbatedisabilityinolderadultsaprospectivecohortanalysisofparticipantsinthememaidtrial
AT fortiercatherineb depressivesymptomsexacerbatedisabilityinolderadultsaprospectivecohortanalysisofparticipantsinthememaidtrial
AT ngolongh depressivesymptomsexacerbatedisabilityinolderadultsaprospectivecohortanalysisofparticipantsinthememaidtrial
AT novakvera depressivesymptomsexacerbatedisabilityinolderadultsaprospectivecohortanalysisofparticipantsinthememaidtrial